ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies

NCT05085548 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Pancreatic Cancer
Solid Tumor Malignancies

Interventions

DRUG: ProAgio Dose Levels (DL) 1,2,3
DRUG: ProAgio Dose Levels (DL) 4,5,6
DRUG: ProAgio Dose Levels 4a,5a,6a

Sponsor

ProDa BioTech, LLC

Collaborators

National Cancer Institute (NCI)